Found: 14
Select item for more details and to access through your institution.
BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3121, doi. 10.3390/cancers13133121
- By:
- Publication type:
- Article
Is extracapsular nodal extension in sentinel nodes a predictor for nonsentinel metastasis and is there an impact on survival parameters?--A retrospective single center cohort study with 324 patients.
- Published in:
- Breast Journal, 2018, v. 24, n. 4, p. 480, doi. 10.1111/tbj.12983
- By:
- Publication type:
- Article
Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 9, p. 1742, doi. 10.1038/s41416-023-02179-0
- By:
- Publication type:
- Article
Ki67 as Proliferative Marker in Patients with Early Breast Cancer and Its Association with Clinicopathological Factors.
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 780, doi. 10.1159/000517490
- By:
- Publication type:
- Article
Changes in Endometriosis-Associated Symptoms Following Immunization against SARS-CoV-2: A Cross-Sectional Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 5, p. 1459, doi. 10.3390/jcm13051459
- By:
- Publication type:
- Article
Extragenital Endometriosis in the Differential Diagnosis of Non- Gynecological Diseases.
- Published in:
- Deutsches Ärzteblatt International, 2022, v. 119, n. 20, p. 361, doi. 10.3238/arztebl.m2022.0176
- By:
- Publication type:
- Article
Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy—results from the prospective multi-center BRENDA II study.
- Published in:
- Breast Cancer (13406868), 2022, v. 29, n. 3, p. 429, doi. 10.1007/s12282-021-01321-1
- By:
- Publication type:
- Article
Three‐dimensional model for improvement of endometriosis care (3D‐E).
- Published in:
- International Journal of Gynecology & Obstetrics, 2024, v. 165, n. 2, p. 416, doi. 10.1002/ijgo.15165
- By:
- Publication type:
- Article
Disturbances of menstrual cycle after immunization against SARS‐CoV‐2 and their risk factors: Cross‐sectional clinical study.
- Published in:
- International Journal of Gynecology & Obstetrics, 2023, v. 163, n. 2, p. 445, doi. 10.1002/ijgo.15060
- By:
- Publication type:
- Article
Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 173, doi. 10.1007/s10549-023-06898-z
- By:
- Publication type:
- Article
Perforated teratoma with multiple cystic lesions throughout the abdomen.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer cases.
- Published in:
- Archives of Gynecology & Obstetrics, 2023, v. 308, n. 6, p. 1831, doi. 10.1007/s00404-023-07130-5
- By:
- Publication type:
- Article
Association of social service counseling in breast cancer patients with financial problems, role functioning and employment—results from the prospective multicenter BRENDA II study.
- Published in:
- Archives of Gynecology & Obstetrics, 2023, v. 307, n. 2, p. 541, doi. 10.1007/s00404-022-06604-2
- By:
- Publication type:
- Article
Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01750-0
- By:
- Publication type:
- Article